HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

(2S,3S)-oxirane-2,3-dicarboxylic acid 2- (((S)- 1- benzylcarbamoyl- 2- phenyl- ethyl)- amide) 3-((2-(4-hydroxy-phenyl)-ethyl)-amide)

Also Known As:

CAA-0225; CAA0225

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Benzyl Compounds: 2
        (2S,3S)-oxirane-2,3-dicarboxylic acid 2-(((S)-1-benzylcarbamoyl-2-phenyl-ethyl)-amide) 3-((2-(4-hydroxy-phenyl)-ethyl)-amide): 1
- Ethers: 242
  - Cyclic Ethers: 12
    - Epoxy Compounds: 689
      - (2S,3S)-oxirane-2,3-dicarboxylic acid 2-(((S)-1-benzylcarbamoyl-2-phenyl-ethyl)-amide) 3-((2-(4-hydroxy-phenyl)-ethyl)-amide): 1
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - Dipeptides: 945
      - (2S,3S)-oxirane-2,3-dicarboxylic acid 2-(((S)-1-benzylcarbamoyl-2-phenyl-ethyl)-amide) 3-((2-(4-hydroxy-phenyl)-ethyl)-amide): 1
- Amino Acids: 30675
  - Essential Amino Acids: 1152
    - Phenylalanine: 4090
      - (2S,3S)-oxirane-2,3-dicarboxylic acid 2-(((S)-1-benzylcarbamoyl-2-phenyl-ethyl)-amide) 3-((2-(4-hydroxy-phenyl)-ethyl)-amide): 1
  - Cyclic Amino Acids: 3
    - Aromatic Amino Acids: 467
      - Phenylalanine: 4090
        (2S,3S)-oxirane-2,3-dicarboxylic acid 2-(((S)-1-benzylcarbamoyl-2-phenyl-ethyl)-amide) 3-((2-(4-hydroxy-phenyl)-ethyl)-amide): 1

Experts

1.	Berry, Colin: 1 article (01/2022)
2.	Carrick, David: 1 article (01/2022)
3.	Channon, Keith M: 1 article (01/2022)
4.	Corcoran, David: 1 article (01/2022)
5.	Davie, Andrew: 1 article (01/2022)
6.	Elliott, Elspeth B: 1 article (01/2022)
7.	Eteiba, Hany: 1 article (01/2022)
8.	Ford, Kristopher: 1 article (01/2022)
9.	Good, Richard: 1 article (01/2022)
10.	Hawksby, Catherine: 1 article (01/2022)

Related Diseases

1.	Reperfusion Injury 01/01/2022 - "Preclinical studies demonstrate that inhibition of cathepsin-L release following reperfusion injury with CAA0225 reduces infarct size and improves cardiac contractile function by limiting abnormal cardiomyocyte calcium handling and apoptosis. "
2.	Infarction (Infarctions) 01/01/2022 - "Preclinical studies demonstrate that inhibition of cathepsin-L release following reperfusion injury with CAA0225 reduces infarct size and improves cardiac contractile function by limiting abnormal cardiomyocyte calcium handling and apoptosis. "

Related Drugs and Biologics

1.	Cathepsin L
2.	Calcium